---
title: 'Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells'
description: 'Study on mefloquine as a SARS-CoV-2 inhibitor'
pubDate: 2022-01-01
refAuthors: 'Sacramento, C.Q., Fintelman-Rodrigues, N., Dias, S.S.G., Temerozo, J.R., Da Silva, A.P.D., da Silva, C.S., Blanco, C., Ferreira, A.C., Mattos, M., Soares, V.C., Pereira-Dutra, F., Miranda, M.D., Barreto-Vieira, D.F., da Silva, M.A.N., Santos, S.S., Torres, M., Chaves, O.A., Rajoli, R.K.R., Paccanaro, A., Owen, A., Bou-Habib, D.C., Bozza, P.T., & Souza, T.M.L.'
refYear: 2022
refTitle: 'Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells'
refJournal: 'Viruses'
refDoi: '10.3390/v14020374'
---

# Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells

For more information, visit the [journal website](https://doi.org/10.3390/v14020374).
